The cantons of Zug and Solothurn in the Greater Zurich Area are ideal locations for Biogen’s international headquarters due to the favorable environment it provides for businesses and employees.
Biogen is where science meets humanity. As pioneers in neuroscience, the company has developed the world’s leading portfolio of treatments for Multiple Sclerosis and developed the world’s first approved treatment for Spinal Muscular Atrophy. Today, Biogen is developing innovative treatments for Alzheimer’s Disease, ALS and many other conditions. Biogen established its international headquarters in the Greater Zurich Area in 2004. Since then the company has grown to more than 450 permanent employees based in Baar, Zug. It is currently investing around 1.5 billion CHF in a next-generation manufacturing facility in Solothurn, adding approximately 400 permanent new jobs by the time it will be fully operational.
The perfect match
Switzerland was an obvious choice for Biogen due to its political stability, predictability and business-friendly environment. The country also has a long tradition in pharmaceuticals development and strong track record on fostering innovation. Greater Zurich Area's central location in Europe and the excellent connectivity by train and air to the most important European markets have helped Biogen develop its business across the region. Biogen has also valued Switzerland as a home to experienced, well-educated and highly diverse talent.
Commitment to science
In keeping with Biogen’s commitment to inspiring young people to consider innovative careers in science, the international headquarters has developed and cultivated long-standing relationships with some of the premier STEM (science, technology, education and math) programs in Switzerland including Swiss Science Center Technorama.
Image credit: Regine Giesecke
Erkenntnisse von Branchenexperten betreffend Talent, Steuern, IP und Standortwahl.
Erfahren Sie mehr über den Erfolg der Life-Sciences-Industrie und die Innovation in der Region.
Erfahren Sie mehr zur Biotechindustrie und Innovation in der Schweiz.
This PDF outlines the key advantages of doing business in Greater Zurich and how we help.
This handbook provides information and data on Switzerland’s key locational advantages.